Norman J. Lassam

3.6k total citations
48 papers, 2.9k citations indexed

About

Norman J. Lassam is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Norman J. Lassam has authored 48 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Oncology and 12 papers in Genetics. Recurrent topics in Norman J. Lassam's work include Cutaneous Melanoma Detection and Management (11 papers), Cancer Genomics and Diagnostics (10 papers) and Virus-based gene therapy research (9 papers). Norman J. Lassam is often cited by papers focused on Cutaneous Melanoma Detection and Management (11 papers), Cancer Genomics and Diagnostics (10 papers) and Virus-based gene therapy research (9 papers). Norman J. Lassam collaborates with scholars based in Canada, United States and Sweden. Norman J. Lassam's co-authors include David Hogg, Irene Leung, Ling Liu, Norman N. Iscove, James R. Woodgett, Lee Anne Tibbles, Friedemann Kiefer, Lynn From, Frank L. Graham and Jose Gerard Monzon and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Norman J. Lassam

48 papers receiving 2.8k citations

Peers

Norman J. Lassam
Andreas Gast Germany
Rosemary A. Walker United Kingdom
Simona Tognin United States
Vladimir Bezrookove United States
Byungwoo Ryu United States
G Vairo Australia
Barbara A. Osborne United States
Andreas Gast Germany
Norman J. Lassam
Citations per year, relative to Norman J. Lassam Norman J. Lassam (= 1×) peers Andreas Gast

Countries citing papers authored by Norman J. Lassam

Since Specialization
Citations

This map shows the geographic impact of Norman J. Lassam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman J. Lassam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman J. Lassam more than expected).

Fields of papers citing papers by Norman J. Lassam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman J. Lassam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman J. Lassam. The network helps show where Norman J. Lassam may publish in the future.

Co-authorship network of co-authors of Norman J. Lassam

This figure shows the co-authorship network connecting the top 25 collaborators of Norman J. Lassam. A scholar is included among the top collaborators of Norman J. Lassam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman J. Lassam. Norman J. Lassam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hogg, David, Ling Liu, & Norman J. Lassam. (2003). Genetic Testing in Familial Melanoma: Epidemiologic/Genetic Assessment of Risks and Role ofCDKN2A Analysis. Humana Press eBooks. 61. 109–122. 7 indexed citations
2.
Youl, Philippa, Joanne F. Aitken, Nicholas K. Hayward, et al.. (2001). Melanoma in adolescents: A case‐control study of risk factors in Queensland, Australia. International Journal of Cancer. 98(1). 92–98. 82 indexed citations
3.
Lynch, Henry T., Randall E. Brand, David Hogg, et al.. (2001). Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families. Cancer. 94(1). 84–96. 163 indexed citations
4.
Nord, Brita, Anton Platz, Soili Kytölä, et al.. (2000). Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of theMEN1 gene in sporadic melanoma. International Journal of Cancer. 87(4). 463–467. 38 indexed citations
5.
Walsh, Scott R., Anne Summers, Lynn From, et al.. (2000). Lack of germline CDK6 mutations in familial melanoma. Oncogene. 19(14). 1849–1852. 19 indexed citations
6.
Yakobson, Emanuel, Esther Azizi, Eyal Winkler, et al.. (2000). Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families. European Journal of Human Genetics. 8(8). 590–596. 21 indexed citations
7.
Fernandez, Conrad V., et al.. (2000). Concurrent Acute Lymphoblastic Leukemia and Juvenile Pilocytic Astrocytoma in a Pediatric Patient. ˜The œAmerican journal of pediatric hematology/oncology. 22(5). 451–453. 2 indexed citations
8.
Dilworth, David, et al.. (2000). Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood. 95(5). 1869–1871. 45 indexed citations
9.
Stewart, A. Keith, Norman J. Lassam, Ian Quirt, et al.. (1999). Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. Gene Therapy. 6(3). 350–363. 108 indexed citations
10.
Liu, Ling, et al.. (1999). Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nature Genetics. 21(1). 128–132. 205 indexed citations
11.
Fernandes, Marie, Christophe Poirier, Norman J. Lassam, et al.. (1997). The mouse homologs of RELA and MLK3 are located within a 120-kb fragment on Chromosome 19. Mammalian Genome. 8(7). 513–515. 4 indexed citations
12.
Lassam, Norman J., et al.. (1997). Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility gene. Human Genetics. 99(6). 776–780. 3 indexed citations
13.
Tibbles, Lee Anne, Friedemann Kiefer, John S.D. Chan, et al.. (1996). MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6.. The EMBO Journal. 15(24). 7026–7035. 279 indexed citations
14.
Winquist, Eric & Norman J. Lassam. (1995). Reversible thrombocytopenia with levamisole. Medical and Pediatric Oncology. 24(4). 262–264. 6 indexed citations
15.
Terman, Bruce I., Lakshmi Khandke, Domenico Maglione, et al.. (1994). VEGF Receptor Subtypes KDR and FLT1 Show Different Sensitivities to Heparin and Placenta Growth Factor. Growth Factors. 11(3). 187–195. 78 indexed citations
16.
Terman, Bruce I., et al.. (1994). Protein kinases in normal and transformed melanocytes. Melanoma Research. 4(5). 313–319. 43 indexed citations
17.
Lassam, Norman J., et al.. (1989). Transgenic approach for the study of pathogenesis induced by human viruses.. PubMed. 6(4). 319–31. 2 indexed citations
18.
Lassam, Norman J., S. T. Bayley, & Frank L. Graham. (1980). Transforming Proteins of Human Adenovirus 5: Studies with Infected and Transformed Cells. Cold Spring Harbor Symposia on Quantitative Biology. 44(0). 477–491. 18 indexed citations
19.
Lassam, Norman J., Stanley T. Bayley, & Frank L. Graham. (1979). Tumor antigens of human ad5 in transformed cells and in cells infected with transformation-defective host-range mutants. Cell. 18(3). 781–791. 57 indexed citations
20.
Lassam, Norman J., S. T. Bayley, & Frank L. Graham. (1978). Synthesis of DNA, late polypeptides, and infectious virus by host-range mutants of adenovirus 5 in nonpermissive cells. Virology. 87(2). 463–467. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026